While PrP-res, a truncated amyloid form of the host protein, can trap infectious particles in its aggregate matrix, and limit their release, the continued production of enormous levels of PrP-res after the FU-CJD agent is cleared has major ramifications for other neurodegenerative diseases, including Alzheimer’s Disease (AD). This evidence concerns the gene PRNP and Creutzfeldt Jacob disease.